SPP1 and myeloid sarcoma: In the comparisons between overall MS and control groups, significant differences in OPN levels in CSF samples were observed only when comparing MS patients vs. HC and NOND (Figure 1C, p = 0.0007), with OPN levels being higher in MS patients.